Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Crohn's Disease Patients
Withdrawal of Immunomodulators After Co-treatment Does Not Reduce Trough Level of Infliximab in Crohn's Disease Patients
A study in the March 2015 issue of CGH finds that withdrawal of immunomodulators after at least 6 months of co-treatment... Read more
2 Apr 2015
•
14mins
Development of Fecal Microbiota Transplantation
Development of Fecal Microbiota Transplantation
An article in the February issue of CGH looks at solutions to issues concerning fecal microbiota transplantation, and ch... Read more
2 Apr 2015
•
17mins
Gastrointestinal Bleeding After Implantation of Ventricular Assist Devices
Gastrointestinal Bleeding After Implantation of Ventricular Assist Devices
An article in the January issue of CGH investigated the incidence, etiology, and outcome of GI bleeding in patients with... Read more
14 Feb 2015
•
14mins
Mesalamine Dosage and Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
Mesalamine Dosage and Fecal Calprotectin in Patients With Quiescent Ulcerative Colitis
A study in the November issue of CGH investigated whether increasing doses of mesalamine reduces concentrations of fecal... Read more
26 Nov 2014
•
15mins
How Gastroenterologists Can Demonstrate Value
How Gastroenterologists Can Demonstrate Value
An AGA Board Strategic Update article in the October issue of CGH discusses recent changes to how a gastroenterologist d... Read more
15 Oct 2014
•
19mins
Restarting Infliximab in IBD Patients with Prior Loss of Response
Restarting Infliximab in IBD Patients with Prior Loss of Response
An article and accompanying editorial in the September issue of CGH discuss reinitiating infliximab therapy for inflamma... Read more
8 Sep 2014
•
17mins
Evolution of Hepatitis C Virus Treatment
Evolution of Hepatitis C Virus Treatment
An editorial in the August issue of CGH discusses changing treatment methods for Hepatitis C Virus infection over the la... Read more
4 Aug 2014
•
16mins
Management of Dyslipidemia as a Cardiovascular Risk Factor in NAFLD Patients
Management of Dyslipidemia as a Cardiovascular Risk Factor in NAFLD Patients
An article in the July issue of CGH looks at management of dyslipidemia as a cardiovascular risk factor in patients with... Read more
2 Jul 2014
•
11mins
PPIs and NSAID–Related Lower Gastrointestinal Adverse Events
PPIs and NSAID–Related Lower Gastrointestinal Adverse Events
A commentary in the June issue of CGH looks at the effect of proton pump inhibitors (PPIs) and nonsteroidal anti-inflamm... Read more
11 Jun 2014
•
13mins
History, Genetics, and Strategies for Cancer Prevention in Lynch Syndrome
History, Genetics, and Strategies for Cancer Prevention in Lynch Syndrome
A review article in the May issue of CGH looks at the major advances in risk assessment, molecular genetics, DNA mutatio... Read more
2 May 2014
•
17mins